NIHR Moorfields Clinical Research Facility (CRF) has cemented an international reputation for developing experimental eye treatments, becoming a destination for world-leading industry research.
Milestones include the first stem cell membrane therapy trial to treat age-related macular degeneration (AMD) and the first gene therapy trial to cure Leber’s congenital amaurosis (LCA), a rare inherited eye disease.
Our services include:
Contact us for more information on our services: moorfields.crfenquiries@nhs.net